...
首页> 外文期刊>The American journal of geriatric pharmacotherapy >Influence of patient age and comorbid burden on clinician attitudes toward heart failure guidelines
【24h】

Influence of patient age and comorbid burden on clinician attitudes toward heart failure guidelines

机译:患者年龄和共病负担对临床医生对心力衰竭指南的态度的影响

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Clinical practice guidelines have been criticized for insufficient attention to the unique needs of patients of advanced age and with multiple comorbid conditions. However, little empiric research is available to inform this topic. Methods: We conducted telephone interviews with staff physicians and nurse practitioners in 4 VA health care systems. Respondents were asked to rate the usefulness of national heart failure guidelines for patients of different ages and levels of comorbid burden on a 5-point scale and to comment on the reasons for their ratings. Results: Of 139 clinicians contacted, 65 (47%) completed the interview. Almost half (49%) were women, and 48 (74%) were general internists or family practitioners. On a 5-point scale assessing the usefulness of clinical practice guidelines for heart failure, the mean (SD) response ranged from 4.4 (0.7) for patients younger than 65 years with few comorbid conditions to 3.5 (1.2) for patients older than 80 years with multiple comorbid conditions (P < 0.001). The difference in perceived usefulness varied more by patient age than by degree of comorbidity (P = 0.02). Four major concepts underlay the perceived usefulness of guidelines across different patient types: (1) harm of treatment and complexity of the patient's clinical condition and pharmacologic needs, (2) expected benefits of treatment, (3) patient preferences and abilities, and (4) confidence in the validity of guideline recommendations. Conclusion: Clinicians perceive heart failure guidelines to be substantially less useful in patients of older age and with greater comorbid burden. Concerns about the clinical and pharmacologic complexity of these patients and the expected benefits of drug therapy were commonly invoked as reasons for this skepticism.
机译:背景:临床实践指南因未充分关注高龄且有多种合并症的患者的独特需求而受到批评。但是,很少有经验研究可以告知这一主题。方法:我们对4种VA卫生保健系统的工作人员医生和护士进行了电话采访。受访者被要求以5分制对不同年龄和不同合并症水平的患者的国家心力衰竭指南的有效性进行评分,并对评分的理由进行评论。结果:在联系的139位临床医生中,有65位(47%)完成了访谈。几乎一半(49%)是女性,而48(74%)是普通内科医生或家庭医生。在5分制量表上评估心力衰竭临床实践指南的有效性,对65岁以下合并症很少的患者的平均(SD)反应范围从4.4(0.7)到80岁以上患者的平均(SD)反应范围为3.5(1.2)有多种合并症(P <0.001)。感知有用性的差异随患者年龄的变化而不是合并症的程度变化(P = 0.02)。四个主要概念奠定了指南对于不同类型患者的有用性:(1)治疗的危害以及患者临床状况和药理学需求的复杂性;(2)治疗的预期收益;(3)患者的偏好和能力;以及(4) )对准则建议有效性的信心。结论:临床医生认为心力衰竭指南在老年患者中没有多大用处,并且合并症负担更大。通常引起对这些患者的临床和药理学复杂性以及药物治疗的预期益处的担忧,作为对此表示怀疑的原因。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号